0001214659-21-006502.txt : 20210611 0001214659-21-006502.hdr.sgml : 20210611 20210611174656 ACCESSION NUMBER: 0001214659-21-006502 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210610 FILED AS OF DATE: 20210611 DATE AS OF CHANGE: 20210611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MESSEMER DEBORAH M. CENTRAL INDEX KEY: 0001754424 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 211012502 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-53109.xml PRIMARY DOCUMENT X0306 4 2021-06-10 0001737287 Allogene Therapeutics, Inc. ALLO 0001754424 MESSEMER DEBORAH M. 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true false false false Stock Option (Right to Buy) 25.76 2021-06-10 4 A false 28015 0.00 A 2031-06-10 Common Stock 28015 28015 D The stock option vests in 12 equal monthly installments beginning July 10, 2021. /s/ Veer Bhavnagri, Attorney-in-Fact 2021-06-11